Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis

Journal of Periodontal Research

Volumn 41, Issue 5, 2006, Pages 477-485

  Cox, S W ^a,b   Rodriguez Gonzalez, E M ^a   Booth, V ^a   Eley, B M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Elastase; Gingival crevicular fluid; Saliva; Secretory leukocyte protease inhibitor

Indexed keywords

ALPHA 1 ANTITRYPSIN; CATHEPSIN B; LEUKOCYTE ELASTASE; SALIVA PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

ADULT; ARTICLE; CHRONIC DISEASE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; IMMUNOBLOTTING; MALE; MIDDLE AGED; PERIODONTITIS; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SALIVA;

ADULT; ALPHA 1-ANTITRYPSIN; CATHEPSIN B; CHRONIC DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNOBLOTTING; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; PERIODONTITIS; SALIVA; SALIVARY PROTEINS; SALIVARY PROTEINS AND PEPTIDES; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEINASE INHIBITORS;

EID: 33748355383     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00891.x     Document Type: Article

References (45)

1. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
2. Eley BM, Cox SW. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: correlation with clinical parameters in untreated chronic periodontitis patients. J Periodont Res 1992;27:62-69.
3. Eley BM, Cox SW. A 2 year longitudinal study of elastase in human gingival crevicular fluid and periodontal attachment loss. J Clin Periodontol 1996;23:681-692.
4. Gustafsson A, Åsman B, Bergström K, Söder P-Ö. Granulocyte elastase in gingival crevicular fluid. A possible discriminator between gingivitis and periodontitis. J Clin Periodontol 1992;19:535-540.
5. Armitage GC, Jeffcoat MK, Chadwick DE et al. Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J Periodontol 1994;65:120-128.
6. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983;52:655-709.
7. Ohlsson K, Ohlsson I, Tynelius-Bratthall G. Neutrophil leukocyte collagenase, elastase and serum protease inhibitors in human gingival crevices. Acta Odont Scand 1973;32:51-59.
8. Giannopoulou C, Andersen E, Demeurisse C, Cimasoni G. Neutrophil elastase and its inhibitors in human gingival crevicular fluid during experimental gingivitis. J Dent Res 1992;71:359-363.
9. 1-antitrypsin in health and disease. Arch Oral Biol 1994;39:301-306.
10. Alavi AL, Palmer RM, Odell EW, Coward PY, Wilson RF. Elastase in gingival crevicular fluid from smokers and non-smokers with chronic inflammatory periodontial disease. Oral Dis 1995;1:110-114.
11. Figueredo CMS, Gustafsson A. Activity and inhibition of elastase in GCF. J Clin Periodontol 1998;25:531-535.
12. Ingman T, Sorsa T, Konttinen YT et al. Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis. Oral Microbiol Immunol 1993;8:298-305.
13. Nieminen A, Nordlund L, Uitto V-J. The effect of treatment on the activity of salivary proteases and glycosidases in adults with advanced periodontitis. J Periodontol 1993;64:297-301.
14. Uitto V-J, Nieminen A, Coil J, Hurttia H, Larjava H. Oral fluid elastase as an indicator of periodontal health. J Clin Periodontol 1996;23:30-37.
15. Fritz H. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol Chem Hoppe-Seyler 1988;369:79-82.
16. Ohlsson M, Rosengren M, Tegner H, Ohlsson K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe-Seylers Zeit Physiol Chem 1983;364:1323-1328.
17. Hiemstra PS. Novel roles of protease inhibitors in infection and inflammation. Biochem Soc Trans 2002;30:116-120.
18. Sallenave J-M. Antimicrobial activity of antiproteinases. Biochem Soc Trans 2002;30:111-115.
19. Wahl SM, McNeely TB, Janoff EN et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis 1997;3:564-569.
20. Sumi Y, Muramatsu H, Hata K, Ueda M, Muramatsu T. Secretory leukocyte protease inhibitor is a novel inhibitor of fibroblast-mediated collagen gel contraction. Exp Cell Res 2000;256:203-212.
21. Angelov N, Moutsopoulos N, Jeong M-J, Nares S, Ashcrofty G, Wahl SM. Aberrent mucosal repair in the absence of secretory leukocyte protease inhibitor. Thromb Haemost 2004;92:288-297.
22. Sallenave J-M, Donnelly SC, Grant IS, Robertson C, Gauldie J, Haslett C. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J 1999;13:1029-1036.
23. Stockley RA, Morrison HM, Kramps JA, Dijkman JH, Burnett D. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment. Thorax 1986;41:442-447.
24. Piccioni PD, Kramps JA, Rudolphus A, Bulgheroni A, Luisetti M. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. Chest 1992;102:1470-1476.
25. Taggart CC, Lowe GJ, Greene CM et al. Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem 2001;276:33345-33352.
26. Cox SW, Eley BM. Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in crevicular fluid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifluoromethyl coumarin. J Periodont Res 1989;24:353-361.
27. Kunimatsu K, Yamamoto K, Ichimura E, Kato Y, Kato I. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J Periodont Res 1990;25:69-73.
28. Eley BM, Cox SW. The relationship between gingival crevicular fluid cathepsin B activity and periodontal attachment loss in chronic periodontitis patients. A 2 year longitudinal study. J Periodont Res 1996;23:681-692.
29. Morita T, Kato H, Iwanaga S, Takada K, Kimura T, Sakakibara S. New fluorogenic substrates for α-thrombin, factor Xa, kallikreins, and urokinase. J Biochem 1977;82:1495-1498.
30. Green GDJ, Shaw E. Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J Biol Chem 1981;256:1923-1928.
31. 2-macroglobulin and cystatin levels in gingival crevicular fluid from periodontitis patients. J Clin Periodontol 1998;25:34-41.
32. Sallenave J-M, Si-Tahar M, Cox G, Chignard M, Gauldie J. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 1997;61:695-702.
33. 1- antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol 1995;40:1151-1155.
34. Nakamura-Minami M, Furuichi Y, Ishikawa K, Mitsuzono-Tofuku Y, Izumi Y. Changes in α1-protease inhibitor and secretory leukocyte protease inhibitor levels in gingival crevicular fluid before and after non-surgical periodontal treatment. Oral Dis 2003;9:249-254.
35. Kennett CN, Cox SW, Eley BM. Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid. J Clin Periodontol 1997;24:424-431.
36. Kennett CN, Cox SW, Eley BM. Localisation of active and inactive elastase, alpha-1-proteinase inhibitor and alpha-2-macroglobulin in human gingiva. J Dent Res 1995;74:667-674.
37. Sas R, Dawes C. The intra-oral distribution of unstimulated and chewing-gum-stimulated parotid saliva. Arch Oral Biol 1997;42:469-474.
38. Cox SW, Eley BM, Proctor GB, Carpenter GH. Elastase inhibitors from gingival homogenates, gingival epithelial cells and saliva. J Dent Res 2001;80:1153.
39. Maruyama M, Hay JG, Yoshimura K, Chu C-S, Crystal RG. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester. J Clin Invest 1994;94:368-375.
40. Abbinante-Nissen JM, Simpson LG, Leikauf GD. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1993;265:L286-L292.
41. Sallenave J-M, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Resp Cell Mol Biol 1994;11:733-741.
42. Fryksmark U, Ohlsson K, Rosengren M, Tegner H. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin. Hoppe-Seylers Zeit Physiol Chem 1983;364:793-800.
43. Murata M, Miyashita S, Yokoo C et al. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett 1991;280:307-310.
44. Gazi M, Cox SW, Clark DT, Eley BM. A comparison of cysteine and serine proteinases in human gingival crevicular fluid with tissue, bacterial and saliva enzymes by analytical isoelectric focusing. Arch Oral Biol 1996;41:393-400.
45. Grenier D. Degradation of host tissue protease inhibitors and activiation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 1996;142:955-961.